kamagra oral jelly 100mg price in pakistan Update-1… 3/19.   speman forte price in india Close is off the lows for Biotech Indices

modalert usa QQQ gap down to $167.10 also at SMA 50

xenical price egypt XBI at SMA 50 bottom of channel at $91.89

beclate aquanase price XLV at $84 approaching February lows of $81

antabuse buy uk It is very difficult to find news or trends that can help us navigate this sell-off where macro news not sector news accounts for the sell-off. Clearly there is less appetite for risk and more uncertainty in markets caused by the daily news cycle. In this situation we can look for specific stocks and trends that find bids on a bad day like today:

prometrium cost australia Alnylam (ALNY)  up 1% to $146.56.  RNAi therapeutics.

glucovance price in india Foundation Medicine (FMI) up 1.19% to $80.80. Personalized Medicine for cancer treatment. Rayno pick.

buy sildalis Jazz Pharmaceuticals (JAZZ) up 1.99%. Sleep, hematology and oncology.

silagra price in bangladesh Nektar Therapeutics (NKTR) up 1.95%. Broad pipeline in immune-oncology and one of best performing stocks in 2018.

buy glucovance online uk Xencor (XNCR) up 2.75%. Mab therapeutics with follow-on stock offering.

tenovate gn buy online  

cresar h price in india =========

unwanted 72 in canada beconase aqueous nasal spray price Broad Sell-Off Triggered By Facebook (FB) Issues

losartan hydrochlorothiazide price Political Backdrop Dulls Market Sentiment- kamagra 100mg oral jelly india price Risk Off Mode

flagyl prescription Social Media Under Fire for Data Mining-Regulation Risk?

proscar order Pre-market prices were down with ongoing issues and breaking news with Facebook  and the sell-off continued through the morning as concerns mount over personal data transactions from Cambridge Analytica . This FB issue coinciding with the aggressive tweets by POTUS taking aim at Mueller did not help market sentiment resulting in a broad sell-off particularly with FAANG and momentum stocks.

Biotechs stocks have followed NASDAQ strength so it is becoming unlikely that we can have a strong biotech rally when leadership tech stocks are selling off. Prices as of 1 PM EDT:

  • QQQ down 2.52%, FBT down 2.38%, IBB down 2.4%,  XBI down 2.5%.
  • Gene editing MO stocks hit again: BLUE CLLS EDIT NTLA SGMO
  • Red screen sweeps large and mid caps. BPMC and NKTR green.

Update after close.

Pin It on Pinterest